Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Test of Treatment in Psychiatric Practice by Feras Ali Mustafa
1
x
$
30.00
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder
1
x
$
0.00
View Cart
Checkout
Home
David C. Steffens, MD, MHS: Cholesterol-Lowering Medication and Relapse of Depression
David C. Steffens, MD, MHS: Cholesterol-Lowering Medication and Relapse of Depression
$
30.00
David C. Steffens, MD, MHS: Cholesterol-Lowering Medication and Relapse of Depression quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 37 No. 4 Articles
Tags:
cholesterol
,
david-c-steffens
,
depression
,
douglas-r-mcquoid
,
elderly
,
k-ranga-rama-krishnan
,
medication
,
relapse
,
vascular
Description
Description
David C. Steffens, MD, MHS
PSYCHIATRIC COMORBIDITIES
Cholesterol-Lowering Medication and Relapse of Depression
David C. Steffens, MD, MHS, Douglas R. McQuoid, BS, and K. Ranga Rama Krishnan, MB, ChB
Related products
In Vivo Neuroimaging Correlates of the Efficacy of Paroxetine in the Treatment of Mood and Anxiety Disorders
$
30.00
Add to cart
Details
Risperidone: Review of Its Therapeutic Utility in Depression
$
30.00
Add to cart
Details
Unraveling the Diagnostic Clues of Depression and GAD: The Primary Care Challenge
$
30.00
Add to cart
Details
New Developments in Depression and Anxiety Disorders
$
30.00
Add to cart
Details
Page load link
Go to Top
